The NT | 合法醫療器材資訊網

Aftervigilantexaminationofresearchliteratureandconferencepapers,Rochelearnedinlate1990oftheNT-proBNPbiomarkerdiscoveryatOslo'sacademic ...

Heart failure (HF) is one of the costliest medical conditions to manage. Its high prevalence, often long hospitalisation stays and frequent readmissions to hospital place a heavy burden on patients, their families and also on healthcare resources.

There had always been an urgent demand for a cost-effective and accurate way to diagnose and manage HF. By 2005, NT-proBNP (N-terminal prohormone of brain natriuretic peptide) as a blood biomarker would fill this gap, becoming a Roche Diagnostics success story. It is an achievement we share with an external partner.

The story begins in the early 1990s. Although Biosite Dia...